GH
Guardant Health Inc
NASDAQ: GH · HEALTHCARE · DIAGNOSTICS & RESEARCH
$83.41
+0.39% today
Updated 2026-04-29
Market cap
$11.06B
P/E ratio
—
P/S ratio
11.26x
EPS (TTM)
$-3.32
Dividend yield
—
52W range
$36 – $121
Volume
2.0M
Guardant Health Inc (GH) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | $116.56M | $342.94M | $587.40M | $962.53M | $2.27B | $2.20B | $1.61B | $1.79B | $1.49B |
| Cash & equivalents | $33.59M | $72.28M | $140.54M | $143.23M | $832.98M | $492.20M | $141.65M | $1.13B | $525.54M |
| Current assets | $103.09M | $242.94M | $468.99M | $597.36M | $1.89B | $1.11B | $1.19B | $1.35B | $1.06B |
| Total liabilities | $36.87M | $34.33M | $62.45M | $114.54M | $916.19M | $1.56B | $1.55B | $1.63B | $1.63B |
| Current liabilities | $14.28M | $19.63M | $46.94M | $72.73M | $66.81M | $194.69M | $193.22M | $205.92M | $225.58M |
| Long-term debt | $16.48M | $460000.00 | — | — | $806.29M | $1.13B | $1.14B | $1.14B | $1.14B |
| Shareholder equity | $79.70M | $308.61M | $483.15M | $798.39M | $1.30B | $645.00M | $60.18M | $158.68M | $-139.65M |
| Retained earnings | $-107.63M | $-195.74M | $-280.80M | $-352.81M | $-606.59M | $-1.01B | $-1.66B | $-2.14B | $-2.58B |
| Accounts receivable | $3.50M | $12.79M | $35.69M | $47.99M | $53.30M | $97.65M | $97.26M | $88.78M | $110.25M |
| Inventory | $2.77M | $7.29M | $9.14M | $15.18M | $22.72M | $30.67M | $51.60M | $61.95M | $71.08M |
| Goodwill | — | — | — | $3.29M | $3.29M | $3.29M | $3.29M | $3.29M | $3.29M |